Is it finally time to buy AMP Limited?

Despite a soaring share price in the past year, AMP Limited (ASX:AMP) remains a long-term underperformer.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to big, blue-chip stocks they don't come much bigger than diversified wealth management firm AMP Limited (ASX: AMP). What's more, with over 850,000 shareholders, thanks to its demutualisation back in 1997, it is also one of the most widely-owned companies in Australia.

Despite its size, AMP hasn't been a particularly fruitful investment – a reminder that size and status doesn't guarantee good investment performance. Over the past decade AMP's share price has actually declined by 17%, in comparison the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is up 41%. Over the more recent past however, things have started looking up for AMP's shareholders with the share price rallying 42% over the last 12 months.

In short, AMP's past performance has left a lot to be desired!

Even the Chairman of AMP Mr Simon McKeon was reported to concede this in the Australian Financial Review recently:

"McKeon admitted the wealth giant's performance had underperformed in the past decade, but argued the company now had the right strategies in place to improve returns – and that they were bearing fruit."

While the past might not have been great, it's important for investors to focus on the future and in that respect there are some reasons to be positive about the potential for AMP to provide adequate returns in the future. Arguably, the biggest positive is the firm's market-leading position in the growing Australian wealth management sector.

Buy, Hold, or Sell?

AMP is due to report its full year results on 19 February. This will offer a timely opportunity for investors to assess how the business units of this industry giant are performing.

According to data provided by Morningstar, AMP is expected to earn 34.8 cents per share for calendar year 2014. Assuming the company meets this forecast the stock is trading on a price-to-earnings ratio of 18.4x. That's above the market multiple, which makes comments by management for earnings growth in 2015 all the more critical to assess and could be at the heart of any decision on whether to allocate a portion of AMP to your portfolio or not.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned.  

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »